KRAS and invasive ductal breast carcinoma: In general, the typical abnormalities of ductal adenocarcinomas including mutations in KRAS, DPC4, p16, and TP53 genes are absent or very rare in ACCs, while the better known pathogenetic mechanism includes abnormalities in the APC/β-catenin pathway (1).